Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verdiperstat in Parkinson's Disease
NCT01603069Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verdiperstat in Parkinson's disease (PD), sponsored by AstraZeneca. Started Oct 2012; status: completed.
02
Drugs
verdiperstat
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01603069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603069.